BEAM

20.8000.67%
CG

Chirfi Guindo

Independent Director

Mr. Chirfi Guindo is Executive Vice President of Strategic Access, Policy & Communications at Merck & Co., Inc. since February 2026. He is an Executive Vice President of Strategic Access, Policy & Communications at Merck Sharp & Dohme LLC and served as its Chief Marketing Officer of Human Health. He is Director at Beam Therapeutics Inc. since December 2024. He served as Chief Marketing Officer for Merck Human Health at Merck & Co since July 01, 2022 until February 2026 and served as its Senior Vice President since July 2022 until February 2026. He served as Executive Vice President and Head of Global Product Strategy and Commercialization at Biogen Inc. until July 2022. He had been an Executive Vice President of Global Product Strategy and Commercialization at Biogen Inc. since February 2019 and served as its Executive Vice President and Head of Global Marketing, Market Access and Customer Innovation since November 7, 2017 until February 2019. Mr. Guindo was Vice President, President and Managing Director of Merck Canada from October 2014 to November 2017. He served as the Managing Director of Merck Sharp & Dohme B.V. He has deep experience in the Merck business around the world, including Managing Director for South Africa and the Netherlands. While in South Africa, as the Chair of Innovative Medicine South Africa (IMSA), he helped forge stronger Partnerships between the government and industry; while in the Netherlands, he led the integration of the Merck and Schering-Plough pharmaceutical businesses, as well as having a leadership role in the Dutch industry association for innovative pharmaceutical companies (Nefarma). In both countries, he was recognized for his collaborative approach with governments on finding sustainable ways to expand access to innovation in healthcare. Mr. Guindo has experience in the global pharmaceutical industry and has held several leadership positions at Merck (known as MSD outside Canada and the USA) in Canada, the USA, France, Africa and the Netherlands. He worked in several disciplines including Finance, Sales & Marketing, General Management and Global Strategy/Product Development in specialty, acute and hospital care. From January 2011 to October 2014, he was Vice President and General Manager, Global HIV Franchise at Merck & Co and led a successful growth strategy across the Merck world, while also collaborating with the Merck Research Labs to advance and expand its HIV research pipeline. He began his career at Merck in 1990 with the Finance department and subsequently accepted a position as a sales Representative in the U.S. Mr. Guindo graduated with a degree in Engineering from Ecole Centrale de Paris (France) and obtained an MBA in Finance and Economics from New York University's Stern School of Business.

Positions